Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vulvar Neoplasms | 3 | 2020 | 263 | 1.500 |
Why?
|
| Uterine Cervical Neoplasms | 7 | 2023 | 2019 | 1.440 |
Why?
|
| Mesentery | 2 | 2020 | 202 | 1.190 |
Why?
|
| Vulva | 2 | 2018 | 84 | 1.090 |
Why?
|
| Hysterectomy | 4 | 2023 | 857 | 0.780 |
Why?
|
| Ureter | 3 | 2020 | 367 | 0.720 |
Why?
|
| Lymph Node Excision | 5 | 2020 | 1271 | 0.700 |
Why?
|
| Pelvic Exenteration | 1 | 2020 | 21 | 0.700 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 358 | 0.670 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 2017 | 16 | 0.610 |
Why?
|
| Ureteral Obstruction | 1 | 2020 | 293 | 0.600 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2017 | 141 | 0.580 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2017 | 66 | 0.560 |
Why?
|
| Angiofibroma | 1 | 2015 | 55 | 0.490 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2017 | 333 | 0.450 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 517 | 0.430 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 1165 | 0.430 |
Why?
|
| Face | 1 | 2017 | 1026 | 0.380 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2024 | 2223 | 0.380 |
Why?
|
| Carcinoma | 2 | 2018 | 2330 | 0.330 |
Why?
|
| Neoplasm Staging | 7 | 2023 | 11106 | 0.290 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 1159 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 4021 | 0.260 |
Why?
|
| Pelvis | 3 | 2019 | 732 | 0.240 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 6339 | 0.220 |
Why?
|
| Lymphatic Metastasis | 2 | 2024 | 2914 | 0.220 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2023 | 137 | 0.200 |
Why?
|
| Inguinal Canal | 2 | 2019 | 71 | 0.190 |
Why?
|
| Postoperative Complications | 4 | 2020 | 15650 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9277 | 0.180 |
Why?
|
| Ligaments | 1 | 2019 | 127 | 0.160 |
Why?
|
| Fascia | 1 | 2019 | 140 | 0.160 |
Why?
|
| Quality of Life | 1 | 2020 | 13361 | 0.150 |
Why?
|
| Pelvic Floor | 1 | 2019 | 137 | 0.150 |
Why?
|
| Organs at Risk | 1 | 2020 | 359 | 0.150 |
Why?
|
| Desiccation | 1 | 2017 | 78 | 0.150 |
Why?
|
| Germany | 1 | 2020 | 875 | 0.150 |
Why?
|
| Endoderm | 1 | 2018 | 160 | 0.140 |
Why?
|
| Cadaver | 2 | 2019 | 1358 | 0.140 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 213 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 3589 | 0.130 |
Why?
|
| Cervix Uteri | 1 | 2019 | 570 | 0.130 |
Why?
|
| Coloring Agents | 1 | 2017 | 559 | 0.120 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 284 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2023 | 54415 | 0.120 |
Why?
|
| Morphogenesis | 1 | 2018 | 741 | 0.110 |
Why?
|
| Collagen | 2 | 2023 | 2638 | 0.110 |
Why?
|
| Prognosis | 3 | 2023 | 29620 | 0.110 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 461 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 2469 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2023 | 80582 | 0.100 |
Why?
|
| Female | 13 | 2023 | 392581 | 0.100 |
Why?
|
| Middle Aged | 9 | 2022 | 220826 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3541 | 0.090 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 6814 | 0.090 |
Why?
|
| Premature Birth | 1 | 2023 | 1782 | 0.090 |
Why?
|
| Humans | 16 | 2024 | 761423 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1725 | 0.090 |
Why?
|
| Surgical Flaps | 1 | 2018 | 1671 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1525 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 3514 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14664 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5246 | 0.070 |
Why?
|
| Aged | 5 | 2018 | 169235 | 0.060 |
Why?
|
| Adult | 6 | 2022 | 221148 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58956 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11073 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10762 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12720 | 0.060 |
Why?
|
| Extraembryonic Membranes | 1 | 2023 | 38 | 0.050 |
Why?
|
| Chorion | 1 | 2023 | 114 | 0.050 |
Why?
|
| Models, Biological | 1 | 2019 | 9469 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 59207 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36423 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2023 | 1970 | 0.040 |
Why?
|
| Perineum | 1 | 2016 | 208 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 22164 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2023 | 1396 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2019 | 1784 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2019 | 1152 | 0.030 |
Why?
|
| Male | 3 | 2019 | 360736 | 0.020 |
Why?
|
| Vagina | 1 | 2016 | 838 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3874 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 88313 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6231 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3466 | 0.020 |
Why?
|
| Intestines | 1 | 2016 | 1909 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 10089 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2023 | 26212 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 29862 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41446 | 0.010 |
Why?
|
Concepts
(91)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_